Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

iShares JPMorgan USD Emerging Markets Bond ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares JPMorgan USD Emerging Markets Bond ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.23 (market cap $12.90B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is far larger — about 7.2× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, iShares JPMorgan USD Emerging Markets Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 50 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

EMBVIR
Market Cap
$12.90B$1.80B
Volume
8,768,6151,782,836
Sector
Fixed IncomeHealth
52-Week High
$97.74$11.78
52-Week Low
$90.14$5.12
Typical Hold Time
50 Days0 Days
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares JPMorgan USD Emerging Markets Bond ETF

EMB trades at $91.26, up 0.2% on the day, with technical indicators showing a bearish bias as moving averages signal selling pressure. The stock faces resistance near $91-92 while support holds at $90. Recent corporate actions include scheduled dividend payments through October 2026, though key valuation metrics remain unavailable for fundamental assessment.

The outlook remains cautious given the bearish technical setup and limited fundamental visibility. Investment opportunity hinges on future financial disclosures, while risks include market volatility from rising bond yields and emerging market exposure. Analyst sentiment suggests EMB's returns will primarily come from yield rather than price appreciation.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EMB

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About iShares JPMorgan USD Emerging Markets Bond ETF

EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.

Read more on EMB →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →